Kirk Daffner, M.D. featured in article, “Alone in the Spotlight but not alone”
Cognitive neurologist sees value in age-focused conversations around Biden’s exit, but also a lack of nuance
Reisa Sperling, M.D. featured in article, “Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimer’s.”
Study suggests genetics are a cause, not just a risk for some with Alzheimer’s.
Kirk Daffner, M.D. was featured in the article, “Alzheimer Monoclonal Antibody Registries: How Will They Work Together and What Data Will Be Collected?”
Patients planning to receive anti-amyloid treatments such as lecanemab first must enroll in a registry to help clinicians draw conclusions on the drugs’ safety and efficacy.
Seth Gale, M.D. featured in, “ANA Investigates the Clinical Implementation of Lecanemab for Alzheimer’s Dementia,” ANA Podcast
Dr. Megan Richie, neurohospitalist at UCSF, spoke to Dr. Seth A. Gale, Co-Director of the Brain Health Program and Assistant Professor of Neurology at Harvard Medical School.
What’s Next for Alzheimer’s Disease: Clinical Trials Show the Promise of Intervening Early
Researchers at the Brigham are developing and advancing treatment options for Alzheimer’s disease by intervening early to prevent the symptoms of the disease, taking aim at new targets, and building on the legacy of the Department of Neurology’s top researchers.
